| MeSH term | MeSH ID | Detail |
|---|---|---|
| Wound Infection | D014946 | 12 associated lipids |
| Respiratory Insufficiency | D012131 | 10 associated lipids |
| Gram-Negative Bacterial Infections | D016905 | 16 associated lipids |
| Hyperbilirubinemia | D006932 | 11 associated lipids |
| Nephritis, Interstitial | D009395 | 10 associated lipids |
| Peptic Ulcer | D010437 | 19 associated lipids |
| Cat-Scratch Disease | D002372 | 4 associated lipids |
| Birth Weight | D001724 | 23 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Cytomegalovirus Infections | D003586 | 7 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Eagan L | Data on HIV infection in women expands. | 1999 | Posit Living | pmid:11367336 |
| Wyrick PB et al. | Persistent chlamydial envelope antigens in antibiotic-exposed infected cells trigger neutrophil chemotaxis. | 1999 | J. Infect. Dis. | pmid:10068592 |
| Shirtliff ME et al. | Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits. | 1999 | Clin. Orthop. Relat. Res. | pmid:10078148 |
| Ong EL | Prophylaxis against disseminated Mycobacterium avium complex in AIDS. | 1999 | J. Infect. | pmid:10090497 |
| Watt G et al. | Azithromycin activities against Orientia tsutsugamushi strains isolated in cases of scrub typhus in Northern Thailand. | 1999 | Antimicrob. Agents Chemother. | pmid:10543774 |
| Schachter J et al. | Azithromycin in control of trachoma. | 1999 | Lancet | pmid:10466664 |
| Chern KC et al. | Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area. | 1999 | Br J Ophthalmol | pmid:10574809 |
| Kutlin A et al. | In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. | 1999 | Antimicrob. Agents Chemother. | pmid:10471577 |
| Bui KQ et al. | Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis. | 1999 | Antimicrob. Agents Chemother. | pmid:10471584 |
| Dunne MW et al. | Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial. California Collaborative Treatment Group. | 1999 | Lancet | pmid:10489947 |
| Blandizzi C et al. | Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases. | 1999 | J. Periodontol. | pmid:10505797 |
| Zarantonelli L et al. | Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. | 1999 | Antimicrob. Agents Chemother. | pmid:10508026 |
| Jackson LA et al. | Safety and effect on anti-Chlamydia pneumoniae antibody titres of a 1 month course of daily azithromycin in adults with coronary artery disease. | 1999 | J. Antimicrob. Chemother. | pmid:10511413 |
| Ghaffar F et al. | Increased carriage of resistant non-pneumococcal alpha-hemolytic streptococci after antibiotic therapy. | 1999 | J. Pediatr. | pmid:10547251 |
| Fong IW et al. | Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model? | 1999 | Clin. Diagn. Lab. Immunol. | pmid:10548582 |
| [Short-term therapy with Azithromycin. Pneumonia-pathogens, most commonly encountered in practice, easily targeted]. | 1999 | Internist (Berl) | pmid:10549000 | |
| Foulds G et al. | The effect of azithromycin on the pharmacokinetics of indinavir. | 1999 | J Clin Pharmacol | pmid:10434237 |
| Umut S et al. | Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor. Turkish Thoracic Society COPD Working Group. | 1999 | J Chemother | pmid:10435684 |
| Krichhoff RM et al. | Determination of azithromycin in gastric biopsy samples. | 1999 | Int J Clin Pharmacol Ther | pmid:10442511 |
| Karcioglu ZA et al. | Pharmacokinetics of azithromycinin rabbit lacrimal glands and conjunctiv a. | 1999 | Ophthalmic Res. | pmid:9831822 |
| Wirnsberger GH et al. | Chronic bacterial inflammation of the gum: the main risk factor for posttransplant gingival hyperplasia? | 1999 | Clin. Nephrol. | pmid:9988152 |
| Scharfstein JA et al. | The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS. | 1999 | Int J Technol Assess Health Care | pmid:10874380 |
| Principi N and Esposito S | Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients. | 1999 | Drug Saf | pmid:9935275 |
| Trautmann M et al. | Combined activity of azithromycin and lansoprazole against Helicobacter pylori. | 1999 | Helicobacter | pmid:10382125 |
| de Vries PI et al. | Short course of azithromycin/artesunate against falciparum malaria: no full protection against recrudescence. | 1999 | Trop. Med. Int. Health | pmid:10402979 |
| Horgan SE et al. | Use of a low nutrient culture medium for the identification of bacteria causing severe ocular infection. | 1999 | J. Med. Microbiol. | pmid:10403423 |
| Donati M et al. | Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp. | 1999 | J. Antimicrob. Chemother. | pmid:10404322 |
| Neiger R et al. | Use of a urea breath test to evaluate short-term treatments for cats naturally infected with Helicobacter heilmannii. | 1999 | Am. J. Vet. Res. | pmid:10407483 |
| Garey KW et al. | Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers. | 1999 | Antimicrob. Agents Chemother. | pmid:10223928 |
| Ouadrhiri Y et al. | Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. | 1999 | Antimicrob. Agents Chemother. | pmid:10223943 |
| Könönen E et al. | beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children. | 1999 | Antimicrob. Agents Chemother. | pmid:10223950 |
| Bergman KL et al. | Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of haemophilus influenzae and Streptococcus pneumoniae. | 1999 | Antimicrob. Agents Chemother. | pmid:10223956 |
| Akova M et al. | In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. | 1999 | Antimicrob. Agents Chemother. | pmid:10223958 |
| Taylor H | Towards the global elimination of trachoma. | 1999 | Nat. Med. | pmid:10229224 |
| Lietman T et al. | Global elimination of trachoma: how frequently should we administer mass chemotherapy? | 1999 | Nat. Med. | pmid:10229236 |
| Ogasawara KK and Goodwin TM | Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery. | 1999 Jan-Feb | J Matern Fetal Med | pmid:10052839 |
| Klapan I et al. | Azithromycin versus amoxicillin/clavulanate in the treatment of acute sinusitis. | 1999 Jan-Feb | Am J Otolaryngol | pmid:9950107 |
| Gorenek L et al. | The diagnosis and treatment of Clostridium difficile in antibiotic-associated diarrhea. | 1999 Jan-Feb | Hepatogastroenterology | pmid:10228818 |
| Braz LM et al. | [The evaluation of the efficacy of azithromycin and pyrimethamine used alone or in combination in the treatment of an experimental infection in mice by Toxoplasma gondii]. | 1999 Jul-Aug | Rev. Soc. Bras. Med. Trop. | pmid:10495670 |
| Sawhney N | MAC prophylaxis in the era of polypharmacy. | 1999 May-Jun | WMJ | pmid:10414219 |
| Schönwald S et al. | Azithromycin: single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome--a randomized study. | 1999 May-Jun | Infection | pmid:10378132 |
| Paavonen J and Eggert-Kruse W | Chlamydia trachomatis: impact on human reproduction. | 1999 Sep-Oct | Hum. Reprod. Update | pmid:10582782 |
| Najib MM et al. | Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia. | 2000 | Pharmacotherapy | pmid:10772376 |
| Krudsood S et al. | A randomized clinical trial of combinations of artesunate and azithromycin for treatment of uncomplicated Plasmodium falciparum malaria in Thailand. | 2000 | Southeast Asian J. Trop. Med. Public Health | pmid:11414432 |
| Khera M | Azithromycin. | 2000 | Conn Med | pmid:11210327 |
| From the Centers for Disease Control and Prevention. Fluoroquinolone resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999. | 2000 | JAMA | pmid:11183745 | |
| West S | The red eye. | 2000 | N. Engl. J. Med. | pmid:11184764 |
| See S | Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients? | 2000 | J Fam Pract | pmid:11052155 |
| Dagan R et al. | Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. | 2000 | Antimicrob. Agents Chemother. | pmid:10602721 |
| Morita JY et al. | Impact of azithromycin on oropharyngeal carriage of group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae. | 2000 | Pediatr. Infect. Dis. J. | pmid:10643849 |
| Fernandez-Obregon AC | Azithromycin for the treatment of acne. | 2000 | Int. J. Dermatol. | pmid:10651967 |
| Valleala H et al. | [The unknown SAPHO]. | 2000 | Duodecim | pmid:12017613 |
| Moshkani SK and Dalimi A | Evaluation of the efficacy of atovaquone alone or in combination with azithromycin against acute murine toxoplasmosis. | 2000 | Vet. Res. Commun. | pmid:10836275 |
| Matute AJ et al. | Is a 5 day course of azithromycin enough for infections caused by Legionella pneumophila? | 2000 | J. Antimicrob. Chemother. | pmid:10837459 |
| Kozyrskyj AL et al. | Short course antibiotics for acute otitis media. | 2000 | Cochrane Database Syst Rev | pmid:10796591 |
| Ghaffar F et al. | Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. | 2000 | Clin. Infect. Dis. | pmid:11049764 |
| Kelley MA et al. | Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. | 2000 | Clin. Infect. Dis. | pmid:11049784 |
| Adachi JA et al. | Empirical antimicrobial therapy for traveler's diarrhea. | 2000 | Clin. Infect. Dis. | pmid:11049792 |
| Renz CL and Ashraf T | Comment: cost-effectiveness of macrolides in lower respiratory tract infections. | 2000 | Ann Pharmacother | pmid:11054992 |
| Boccazzi A et al. | Short course therapy with cefitbuten versus azithromycin in pediatric streptococcal pharyngitis. | 2000 | Pediatr. Infect. Dis. J. | pmid:11055597 |
| Frenck RW et al. | Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. | 2000 | Clin. Infect. Dis. | pmid:11073741 |
| Westphal JF | Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin. | 2000 | Br J Clin Pharmacol | pmid:11012550 |
| Dunne M et al. | A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus. | 2000 | Clin. Infect. Dis. | pmid:11073759 |
| Krause PJ et al. | Atovaquone and azithromycin for the treatment of babesiosis. | 2000 | N. Engl. J. Med. | pmid:11078770 |
| Granowitz EV et al. | Potentially fatal interaction between azithromycin and disopyramide. | 2000 | Pacing Clin Electrophysiol | pmid:11025903 |
| Semaan HB et al. | The effect of chronic azithromycin therapy on soluble endothelium-derived adhesion molecules in patients with coronary artery disease. | 2000 | J. Cardiovasc. Pharmacol. | pmid:11026657 |
| Fonck K et al. | A randomized, placebo-controlled trial of monthly azithromycin prophylaxis to prevent sexually transmitted infections and HIV-1 in Kenyan sex workers: study design and baseline findings. | 2000 | Int J STD AIDS | pmid:11138916 |
| Bogdanov MB and Chernen'kaia TV | [Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract]. | 2000 | Antibiot. Khimioter. | pmid:11212394 |
| Budanov SV | [Azithromycin (sumamed)--basic properties and therapy of community-acquired pneumonia]. | 2000 | Antibiot. Khimioter. | pmid:11212397 |
| Bregani ER et al. | Azithromycin in the treatment of Plasmodium falciparum gametocytes. Preliminary observation. | 2000 | Panminerva Med | pmid:11218625 |
| Ianaro A et al. | Anti-inflammatory activity of macrolide antibiotics. | 2000 | J. Pharmacol. Exp. Ther. | pmid:10604943 |
| Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999. | 2000 | MMWR Morb. Mortal. Wkly. Rep. | pmid:11012233 | |
| Erhardt W et al. | Establishing criteria for assessment of efficacy of antimicrobial agents in acute otitis media. | 2000 | Antimicrob. Agents Chemother. | pmid:11012390 |
| Currier JS et al. | Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team. | 2000 | Ann. Intern. Med. | pmid:11015162 |
| Vranes J | Effect of subminimal inhibitory concentrations of azithromycin on adherence of Pseudomonas aeruginosa to polystyrene. | 2000 | J Chemother | pmid:10949976 |
| Dean D et al. | Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. | 2000 | J. Infect. Dis. | pmid:10950788 |
| Rekart M et al. | Mass treatment/prophylaxis during an outbreak of infectious syphilis in Vancouver, British Columbia. | 2000 | Can. Commun. Dis. Rep. | pmid:10932390 |
| Vergis EN et al. | Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. | 2000 | Arch. Intern. Med. | pmid:10809032 |
| Ng DK et al. | A randomized controlled trial of azithromycin and amoxycillin/clavulanate in the management of subacute childhood rhinosinusitis. | 2000 | J Paediatr Child Health | pmid:10940175 |
| Mandell GL and Coleman EJ | Activities of antimicrobial agents against intracellular pneumococci. | 2000 | Antimicrob. Agents Chemother. | pmid:10952618 |
| Thompson C | Azithromycin v oxytetracycline for the treatment of non-specific urethritis. | 2000 | Sex Transm Infect | pmid:10961211 |
| Jonas D et al. | The effect of azithromycin on intracellular Legionella pneumophila in the Mono Mac 6 cell line at serum concentrations attainable in vivo. | 2000 | J. Antimicrob. Chemother. | pmid:10980164 |
| Beckey NP et al. | Retrospective evaluation of a potential interaction between azithromycine and warfarin in patients stabilized on warfarin. | 2000 | Pharmacotherapy | pmid:10999497 |
| Schneider CA et al. | In vivo uptake of azithromycin in human coronary plaques. | 2000 | Am. J. Cardiol. | pmid:11018204 |
| Heikkinen T et al. | The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. | 2000 | BJOG | pmid:10847234 |
| Nishi Y et al. | [Effect of macrolide antibiotics on adhesion by cancer cells]. | 2000 | Jpn J Antibiot | pmid:10756450 |
| Wenisch C | [Pharmacokinetic effects of antibiotics on the development of bacterial resistance particularly in reference to azithromycin]. | 2000 | Wien Med Wochenschr | pmid:10756595 |
| Giacometti A et al. | Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines. | 2000 | J. Antimicrob. Chemother. | pmid:10702561 |
| Hammerschlag MR | Treatment of Chlamydia pneumoniae. | 2000 | Int. J. Antimicrob. Agents | pmid:10926449 |
| Slavinsky J et al. | Factors associated with the decline in sexually transmitted infections among HIV-positive women. | 2000 | J. Acquir. Immune Defic. Syndr. | pmid:10708065 |
| Angelilli ML et al. | Palatability of oral antibiotics among children in an urban primary care center. | 2000 | Arch Pediatr Adolesc Med | pmid:10710025 |
| Dagan R et al. | Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. | 2000 | Pediatr. Infect. Dis. J. | pmid:10693993 |
| Bowden FJ et al. | Donovanosis causing cervical lymphadenopathy in a five-month-old boy. | 2000 | Pediatr. Infect. Dis. J. | pmid:10694010 |
| Rino BE et al. | Azithromycin in the treatment of plasmodium falciparum gametocytes: a preliminary observation. | 2000 | J. Trop. Pediatr. | pmid:10730047 |
| Plouffe J et al. | Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group. | 2000 | Antimicrob. Agents Chemother. | pmid:10858333 |
| Canut Blasco A et al. | [A randomized, prospective and comparative study is a clinical trial]. | 2000 | Med Clin (Barc) | pmid:10734631 |
| Vcev A et al. | Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer. | 2000 | Aliment. Pharmacol. Ther. | pmid:10632647 |
| Donders GG | Treatment of sexually transmitted bacterial diseases in pregnant women. | 2000 | Drugs | pmid:10776830 |
| Potts JM et al. | Association of chronic urinary symptoms in women and Ureaplasma urealyticum. | 2000 | Urology | pmid:10736488 |
| Puri SK and Singh N | Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys. | 2000 | Exp. Parasitol. | pmid:10631075 |